Press and media releases
9 October 2014: LUDWIG BOELKOW AWARD 2014, neoplas tools GmbH was honoured with the Technology award for the kINPen MED®
In October 2014 the kINPen MED® was honoured with the Ludwig-Boelkow-Award 2014 of Mecklenburg-Vorpommern for a successful economic valorisation of results in research and development.
Neoplas tools GmbH is introduced as the manufacturer of kINPen MED ® the first cold plasma device certified as medical device for treatment of chronic wounds and pathogen-caused diseases of the skin. Dr. med. Dirk Barnstorf, non-executive senior physician and specialist for vascular surgery in the hospital Diakoniekrankenhaus Henriettenstiftung Hanover, Germany, reports on his positive experiences in e.g. treating varicose veins with ulcer or ulcerated legs of patients with diabetes.
And Univ.-Prof. Dr. med Dr. med. dent. Hans-Robert Metelmann, Director of the Clinic and Policlinic of Oral and Maxillofacial Surgery at the University Medicine Greifswald, looks out on the application of physical plasma in tumour therapy. Plasmamedical research is conducted in close collaboration with the INP Greifswald.
September 2014 Physical Plasma – The Future in Skin Treatment - A short film for the MEDICA, the world’s leading trade fair for the healthcare
Prof. Klaus-Dieter Weltmann of the Leibniz Institute for Plasma Science and Technology e.V. (INP) in Greifswald speaks about generating physical plasmas and its possibilities in medicine. Dr. Georg Daeschlein of the University Medicine Greifswald describes advantages of plasma treatments in Dermatology. The film is in German language.
Plasmamedical research at the INP
At a tumour excision single cancer cells or cell clusters could remain at wound margins and cause another necessary surgery. Prof. Hans-Robert Metelmann and Dr. Christian Seebauer from the University Medicine Greifswald explain in the MEDICA-Video, how physical plasmas could help in future. Dr. Kai Masur of the Leibniz Institute for Plasma Science and Technology e.V. (INP Greifswald) illustrates, how plasmas deactivate cancer cells.